drug discovery
Syntegra Teams With Vanderbilt's Nashville Biosciences on Biobank Data Analysis for Drug R&D
Data analysis firm Syntegra will work with NashBio to produce and validate synthetic data from the BioVU biobank, starting with type 2 diabetes.
ERS Genomics Licenses CRISPR Patents to Nuvisan
Nuvisan, based in Waltrop, Germany, will use ERS'w Genomics CRISPR-Cas9 portfolio to help advance its clients' drug discovery and early development programs.
Enpicom, Viroclinics-DDL Expand Partnership to Accelerate Antibody, Vaccine Discovery
A Dutch province has awarded an unspecified sum to the Netherlands-based firms to combine their technologies for TCR and BCR repertoire sequencing and analysis.
Cleveland Clinic, IBM Partner on High-Performance Computing for Life Science, Healthcare Research
Under their 10-year partnership, IBM will install an early instance of its Quantum System One at Cleveland Clinic to promote AI-driven life sciences discovery.
Genialis Teams With Slovenian Bioinformatics Group to Develop Precision Medicine Tools
Genialis' Expressions software is helping the University of Ljubljana's BioLab develop new methods to match patients to therapies based on their disease subtype.